deoxycytidine has been researched along with Adenoma, Basal Cell in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (42.86) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Guo, Y; Lin, Z | 1 |
Bruce, JN; Carminucci, AS; Fine, RL; Gulati, AP; Lignelli, A; Remotti, H; Siegelin, M; Wardlaw, SL; Zacharia, BE | 1 |
Bruce, JN; Fine, RL; Freda, PU; Isaacson, SR; Lee, Y; Thearle, MS | 1 |
Majumdar, AP; Patel, BB | 1 |
Choi, DW; Choi, SH; Heo, JS; Jang, KT; Kim, EJ; Kim, JO; Lee, EM; Lee, JK; Lee, KH; Lee, KT; Min, SY; Park, YG | 1 |
Ali, S; El-Rayes, BF; Philip, PA; Sarkar, FH | 1 |
Bartsch, H; Nair, J; Schmid, K; Velic, I; Winde, G | 1 |
1 review(s) available for deoxycytidine and Adenoma, Basal Cell
Article | Year |
---|---|
Synergistic role of curcumin with current therapeutics in colorectal cancer: minireview.
Topics: Adenoma; Animals; Anticarcinogenic Agents; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Colorectal Neoplasms; Curcumin; Deoxycytidine; Fluorouracil; Gastrointestinal Neoplasms; Gemcitabine; Humans; Organoplatinum Compounds; Oxaliplatin; Treatment Outcome | 2009 |
6 other study(ies) available for deoxycytidine and Adenoma, Basal Cell
Article | Year |
---|---|
Efficacy of XELOX adjuvant chemotherapy for gastric mixed adenoneuroendocrine carcinoma: A case report.
Topics: Adenoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Carcinoma, Neuroendocrine; Chemotherapy, Adjuvant; Deoxycytidine; Fluorouracil; Humans; Male; Middle Aged; Mixed Tumor, Malignant; Oxaloacetates; Stomach Neoplasms; Treatment Outcome | 2019 |
High response rates and prolonged survival in patients with corticotroph pituitary tumors and refractory Cushing disease from capecitabine and temozolomide (CAPTEM): a case series.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Dacarbazine; Deoxycytidine; Female; Fluorouracil; Humans; Immunohistochemistry; Male; Middle Aged; Pituitary ACTH Hypersecretion; Temozolomide | 2014 |
Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumor.
Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Dacarbazine; Deoxycytidine; Fluorouracil; Humans; Male; Middle Aged; Neoplasm Invasiveness; Radiography; Temozolomide; Treatment Outcome | 2011 |
[MicroRNA expression pattern in intraductal papillary mucinous neoplasm].
Topics: Adenocarcinoma, Mucinous; Adenoma; Aged; Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Papillary; Cell Line; Deoxycytidine; Female; Gemcitabine; Humans; Male; MicroRNAs; Middle Aged; Pancreatic Neoplasms; Real-Time Polymerase Chain Reaction; Up-Regulation | 2011 |
Protein kinase C: a target for therapy in pancreatic cancer.
Topics: Adenocarcinoma; Adenoma; Antineoplastic Combined Chemotherapy Protocols; Bryostatins; Cell Survival; Deoxycytidine; Gemcitabine; Humans; Isoenzymes; Pancreatic Neoplasms; Protein Kinase C; Protein Kinase Inhibitors; Reference Values | 2008 |
Increased levels of promutagenic etheno-DNA adducts in colonic polyps of FAP patients.
Topics: Adenoma; Adenomatous Polyposis Coli; Adult; Aged; Aged, 80 and over; Colon; Colonic Polyps; Colorectal Neoplasms; Deoxyadenosines; Deoxycytidine; DNA Adducts; Female; Humans; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress | 2000 |